|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6043376A
(en)
*
|
1998-08-06 |
2000-03-28 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis of alpha-methyl, alpha-substituted amino acids
|
|
US6110922A
(en)
|
1998-12-29 |
2000-08-29 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
|
|
US6878700B1
(en)
|
1998-12-29 |
2005-04-12 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
|
|
US6867203B2
(en)
|
1998-12-29 |
2005-03-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
|
|
WO2001007044A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
|
WO2001007052A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
|
US6492408B1
(en)
*
|
1999-07-21 |
2002-12-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
|
JP3833532B2
(ja)
|
1999-07-21 |
2006-10-11 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
炎症性疾患の治療において有用な小分子
|
|
US6897225B1
(en)
|
1999-10-20 |
2005-05-24 |
Tanabe Seiyaku Co., Ltd. |
Inhibitors of αLβ2 mediated cell adhesion
|
|
US20040077605A1
(en)
|
2001-06-20 |
2004-04-22 |
Salvati Mark E. |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
|
US7001911B2
(en)
|
2000-06-28 |
2006-02-21 |
Bristol-Myers Squibb Company |
Fused cyclic modulators of nuclear hormone receptor function
|
|
MXPA02012605A
(es)
|
2000-06-28 |
2003-05-14 |
Squibb Bristol Myers Co |
Moduladores selectivos del receptor androgeno y metodo para su identificacion, dise°o y uso.
|
|
US6521619B2
(en)
|
2000-06-29 |
2003-02-18 |
Icos Corporation |
Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
|
|
EP1294704A1
(en)
|
2000-06-29 |
2003-03-26 |
Abbott Laboratories |
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
US6846643B2
(en)
*
|
2000-08-14 |
2005-01-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
|
|
US6953679B2
(en)
|
2000-09-19 |
2005-10-11 |
Bristol-Myers Squibb Company |
Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
|
|
US6710064B2
(en)
|
2000-12-01 |
2004-03-23 |
Bristol-Myers Squibb Co. |
Hydantoin compounds useful as anti-inflammatory agents
|
|
WO2002050080A1
(en)
*
|
2000-12-19 |
2002-06-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
|
CN1582279A
(zh)
*
|
2001-11-30 |
2005-02-16 |
伊莱利利公司 |
过氧化物酶体激活的受体激动剂
|
|
US7087636B2
(en)
|
2001-12-19 |
2006-08-08 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
|
|
TW200303200A
(en)
|
2002-02-07 |
2003-09-01 |
Tanabe Seiyaku Co |
Inhibitors of α L β 2 integrin mediated cell adhesion
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1539744A4
(en)
|
2002-07-11 |
2007-06-06 |
Vicuron Pharm Inc |
N-HYDROXYAMIDE DERIVATIVES WITH ANTIBACTERIAL EFFECT
|
|
WO2004032861A2
(en)
|
2002-10-11 |
2004-04-22 |
Bristol-Myers Squibb Company |
Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
|
|
US6844360B2
(en)
|
2002-10-30 |
2005-01-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
|
|
US6852748B1
(en)
|
2002-10-30 |
2005-02-08 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide
|
|
US7354933B2
(en)
|
2003-01-31 |
2008-04-08 |
Aventis Pharma Sa |
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
FR2850652B1
(fr)
*
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
EP2384753B1
(en)
*
|
2003-08-29 |
2016-01-06 |
The Brigham and Women's Hospital, Inc. |
Hydantoin derivatives as inhibitors of cellular necrosis
|
|
US7199125B2
(en)
|
2003-10-02 |
2007-04-03 |
Bristol-Myers Squibb Company |
Spiro-cyclic compounds useful as anti-inflammatory agents
|
|
DOP2005000123A
(es)
*
|
2004-07-02 |
2011-07-15 |
Merck Sharp & Dohme |
Inhibidores de cetp
|
|
KR20070032787A
(ko)
*
|
2004-07-16 |
2007-03-22 |
쉐링 코포레이션 |
염증 질환 치료용 히단토인 유도체
|
|
RU2007106927A
(ru)
*
|
2004-07-27 |
2008-09-10 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Синтез амидов 6,7,-дигидро-5н-имидазо [1.2-а] имидазол-3-сульфоновой кислоты
|
|
EP1621535A1
(en)
*
|
2004-07-27 |
2006-02-01 |
Aventis Pharma S.A. |
Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
|
|
US7375237B2
(en)
|
2004-08-18 |
2008-05-20 |
Bristol-Myers Squibb Company |
Pyrrolizine compounds useful as anti-inflammatory agents
|
|
TW200616634A
(en)
|
2004-10-01 |
2006-06-01 |
Bristol Myers Squibb Co |
Crystalline forms and process for preparing spiro-hydantoin compounds
|
|
JPWO2006051937A1
(ja)
*
|
2004-11-15 |
2008-05-29 |
塩野義製薬株式会社 |
ヘテロ５員環誘導体
|
|
US7186727B2
(en)
|
2004-12-14 |
2007-03-06 |
Bristol-Myers Squibb Company |
Pyridyl-substituted spiro-hydantoin compounds and use thereof
|
|
EP1838348B1
(en)
|
2004-12-15 |
2013-06-26 |
Janssen Alzheimer Immunotherapy |
Humanized amyloid beta antibodies for use in improving cognition
|
|
WO2007027233A2
(en)
|
2005-05-19 |
2007-03-08 |
Boehringer Ingelheim International, Gmbh |
Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid
|
|
WO2007047146A2
(en)
*
|
2005-10-11 |
2007-04-26 |
Intermune, Inc. |
Inhibitors of viral replication
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
US8168667B2
(en)
|
2006-05-31 |
2012-05-01 |
Galapagos Nv |
Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
MX2010004995A
(es)
|
2007-11-29 |
2010-05-20 |
Boehringer Ingelheim Int |
Derivados de amidas del acido 6,7-dihidro-5h-imidazo[1,2-a]imidazo l-3-carboxilico.
|
|
GB2463514C
(en)
|
2008-09-11 |
2018-09-26 |
Galapagos Nv |
Imidazolidine compounds and uses therefor
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
JP2012513481A
(ja)
|
2008-12-23 |
2012-06-14 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
ネクロトーシスの小分子阻害剤
|
|
ITBO20090078A1
(it)
*
|
2009-02-13 |
2010-08-14 |
Consiglio Nazionale Ricerche |
Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi
|
|
WO2010141330A1
(en)
|
2009-06-02 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
|
|
BRPI1012581A2
(pt)
|
2009-06-02 |
2016-03-29 |
Boehringer Ingelheim Int |
derivados de amidas de ácido 6, 7-di-hidro-5h-imidazol[1,2-a]imidazol-3-carboxílico
|
|
CN102731525A
(zh)
*
|
2011-04-08 |
2012-10-17 |
上海艾力斯医药科技有限公司 |
苯并吗啉衍生物
|
|
US20160024098A1
(en)
|
2013-03-15 |
2016-01-28 |
President And Fellows Of Harvard College |
Hybrid necroptosis inhibitors
|
|
SG10202006105XA
(en)
*
|
2014-06-12 |
2020-07-29 |
Allocyte Pharmaceuticals Ag |
Small molecule lfa-1 inhibitors
|
|
AR102942A1
(es)
|
2014-12-11 |
2017-04-05 |
Bayer Cropscience Ag |
Derivados de arilsulfuro y arilsulfóxido de cinco miembros c-n-conectados, como plaguicidas
|
|
SG11201704764PA
(en)
|
2014-12-11 |
2017-07-28 |
Harvard College |
Inhibitors of cellular necrosis and related methods
|
|
CN113024513A
(zh)
*
|
2021-03-22 |
2021-06-25 |
中国药科大学 |
新型雄激素受体降解剂、制备方法和医药用途
|
|
WO2026045350A1
(en)
*
|
2024-09-02 |
2026-03-05 |
Innocare Pharma Inc. |
Heterocyclic vav1 degraders
|